Keith Lamont Cummings, Chief Financial Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 35,483 shares at $30.21 ($1.1M) on 2020-12-01, disclosed to the SEC on 2020-12-02.
Open-market sale of $1.1M PLRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.24 | 1,139 | $32K | 3.0% |
| 2 | $29.07 | 1,848 | $54K | 5.0% |
| 3 | $29.07 | 1,848 | $54K | 5.0% |
| 4 | $30.21 | 14,901 | $450K | 42.2% |
| 5 | $30.21 | 14,901 | $450K | 42.2% |
| 6 | $30.72 | 846 |
| $26K |
| 2.4% |
| Total | $30.04 avg | 35,483 | $1.1M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $252K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $337K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $712K | — | Filing → |